TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data Private Market Index IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
Private Market Index
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Sojournix Stock

Sojournix Stock

sojournixpharma.comHealthcareFounded: 1900Funding to Date: $71.39MM

Sojournix is a clinical stage biopharmaceutical company focused on developing and commercializing novel therapies for the treatment of women’s health and neuroendocrine disorders.

Buy or sell Sojournix stockLearn more about Sojournix IPO
Register for Details

For more details on financing and valuation for Sojournix, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Sojournix.

Register Today

Team

Management Team

Scott Rakestraw
Board Member & Co-Founder
Daniel Grau
Co-Founder, President, Chief Executive Officer, and Director

Board Members

Martin Freed MD
Peter Kolchinsky
Daniel Grau
Scott Rakestraw
Aaron Davis
Tavistock Group
Peter Lanciano

Other companies like Sojournix in the Healthcare sector

Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
Acelyrin
Sector
Healthcare
Last Round Est. Valuation
$809.52MM
Paradromics
Sector
Healthcare
 
 
Colossal Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.01B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
OURA
Sector
Healthcare
 
 
Alzheon
Sector
Healthcare
Last Round Est. Valuation
$1.53B
Artera
Sector
Healthcare
Last Round Est. Valuation
$396.01MM

News

FinSMEs 01/03/2019
Sojournix Completes $44M Series C Financing | FinSMEs
Sojournix, a developer of new medicines for the treatment of women's health and neuroendocrine disorders, completed a $44m Series C financing

Trending Companies

Frequently Asked Questions

Updated on: Jun 8, 2023